The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction

Christina Chrysohoou1, Natasa Kollia2, Dimitris Tousoulis1

  • 1First Cardiology Clinic, School of Medicine, University of Athens, Athens, Greece.

Maturitas
|February 18, 2018
PubMed

Insights

Depression and vital exhaustion significantly elevate cardiovascular disease risk. This review explores inflammation and endothelial dysfunction as key biological links, suggesting a complex feedback loop between depression and atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Psychiatry
  • Immunology

Background:

  • Major depressive disorder and sub-syndromal depressive symptoms increase cardiovascular morbidity and mortality.
  • Vital exhaustion, a state of emotional and physical overstrain, shares overlapping characteristics with depression and is linked to cardiovascular risk.
  • The precise pathophysiological mechanisms connecting depressive symptoms to atherosclerosis remain incompletely understood.

Purpose of the Study:

  • To review the role of inflammation and endothelial dysfunction in the relationship between depressive symptoms and atherosclerosis.
  • To explore the bidirectional interaction between systemic inflammation and psychological factors in cardiovascular disease.

Main Methods:

  • Literature review of studies investigating biological pathways linking depression and atherosclerosis.
  • Examination of research on inflammation, endothelial dysfunction, and their interplay with depressive symptoms.
  • Analysis of evidence regarding the directionality of the association between inflammation and depression.

Main Results:

  • Systemic inflammation and endothelial dysfunction are implicated as biological mediators in the depression-atherosclerosis link.
  • Evidence suggests a complex interplay between psychological factors and inflammatory processes.
  • The relationship between inflammation and depression may be bidirectional, with distinct biological pathways for each direction.

Conclusions:

  • Inflammation and endothelial dysfunction represent critical biological factors contributing to the elevated cardiovascular risk associated with depressive symptoms.
  • A feedback relationship between depression and inflammation is suggested, necessitating further research into specific biological pathways.
  • Clarifying these mechanisms is crucial for developing targeted interventions for cardiovascular disease prevention in individuals with depressive symptoms.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
62.5K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
481
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
451
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.2K